COVID-19患者における高血圧薬の影響

Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
 de Abajo FJ, et al.　〔Lancet. 2020 May 30;395(10238):1705-1714〕（査読済み）


Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis.
 Guo X, et al.　〔Hypertension. 2020 May 27〕（査読済み）